Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia 10Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Accelerated Phase 9Lymphoma, Mantle-Cell 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Congenital Abnormalities 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Renal Cell 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, T-Cell, Cutaneous 4Recurrence 3

Interventions

Rituximab 4Lenalidomide 2veliparib 1romidepsin 1liposomal doxorubicin 1fludarabine phosphate 1flt3 ligand protein 1ethanolamine oleate 1Whole-Body Irradiation 1Vincristine 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thrombopoietin 1Sulfamethoxazole 1Stem Cell Factor 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Mycophenolic Acid 1Ipilimumab 1Filgrastim 1Etoposide 1Ethanol 1Edetic Acid 1Doxorubicin 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Intraocular Lymphoma × Mycophenolic Acid × Clear all
NCT00006251 2020-01-21

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
21 enrolled
DermatologicGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡